Royal Bank of Canada’s MaxCyte MXCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1K Sell
1,299
-3,287
-72% -$3.07K ﹤0.01% 6912
2025
Q4
$7K Buy
4,586
+426
+10% +$680 ﹤0.01% 6591
2025
Q3
$6K Sell
4,160
-6,578
-61% -$11.4K ﹤0.01% 6652
2025
Q2
$23K Buy
10,738
+3,945
+58% +$9.55K ﹤0.01% 6215
2025
Q1
$19K Sell
6,793
-7,360
-52% -$29K ﹤0.01% 5936
2024
Q4
$59K Buy
14,153
+3,291
+30% +$12.4K ﹤0.01% 5604
2024
Q3
$42K Buy
10,862
+1,021
+10% +$4.3K ﹤0.01% 5788
2024
Q2
$39K Buy
9,841
+5,558
+130% +$23.9K ﹤0.01% 5768
2024
Q1
$18K Sell
4,283
-19,448
-82% -$91.3K ﹤0.01% 5966
2023
Q4
$112K Buy
23,731
+7,962
+50% +$31K ﹤0.01% 5549
2023
Q3
$49K Buy
15,769
+6,607
+72% +$26.6K ﹤0.01% 5793
2023
Q2
$42K Buy
9,162
+4,091
+81% +$18.8K ﹤0.01% 5859
2023
Q1
$25K Sell
5,071
-6,773
-57% -$33.4K ﹤0.01% 5944
2022
Q4
$65K Buy
11,844
+10,619
+867% +$65.1K ﹤0.01% 5743
2022
Q3
$8K Buy
1,225
+570
+87% +$3.18K ﹤0.01% 6538
2022
Q2
$3K Sell
655
-5,651
-90% -$27.8K ﹤0.01% 6841
2022
Q1
$44K Sell
6,306
-14,203
-69% -$97K ﹤0.01% 6178
2021
Q4
$209K Buy
20,509
+18,597
+973% +$200K ﹤0.01% 5295
2021
Q3
$23K Buy
+1,912
New +$28.8K ﹤0.01% 6632

Other funds holding MXCT

Royal Bank of Canada's MXCT Position: Q1 2026 in Review

Royal Bank of Canada reduced its MaxCyte (MXCT) stake by 72% in Q1 2026, selling an estimated $3.07K and leaving 1,299 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #6912.

Royal Bank of Canada first reported a position in MXCT in Q3 2021 and has held it in 19 quarters since. The position peaked at $209K in Q4 2021. 130 funds tracked by Wall St. Rank hold MXCT as of Q1 2026.

  • Royal Bank of Canada held 1,299 shares of MaxCyte worth $1K as of Q1 2026.
  • Royal Bank of Canada sold 3,287 MaxCyte shares in Q1 2026, an estimated $3.07K.
  • MaxCyte made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #6912 holding.
  • Royal Bank of Canada first reported a position in MaxCyte in Q3 2021 and has held it in 19 quarters since.
  • Royal Bank of Canada's MaxCyte position peaked at $209K in Q4 2021.
  • 130 funds tracked by Wall St. Rank held MaxCyte as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.